Roles of activin in tissue repair, fibrosis, and inflammatory disease

Cytokine and Growth Factor Reviews

Volumn 17, Issue 3, 2006, Pages 157-171

  Werner, Sabine ^a   Alzheimer, Christian ^b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Activin; Apoptosis; Follistatin; Inflammation; Regeneration; Wound healing

Indexed keywords

ACTIVIN; ACTIVIN A; ACTIVIN INHIBITOR; ANTIFIBROTIC AGENT; BETACELLULIN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLLISTATIN; GLUCOCORTICOID; PROTEIN INHIBITOR; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ANTIINFLAMMATORY ACTIVITY; ARTHROPATHY; ASTHMA; ATHEROSCLEROSIS; BONE REMODELING; BRAIN INJURY; COLITIS; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM INFLAMMATION; FIBROSIS; HUMAN; INFLAMMATORY DISEASE; KIDNEY FIBROSIS; LIVER FIBROSIS; LIVER REGENERATION; LUNG FIBROSIS; MENINGITIS; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCAR FORMATION; TISSUE REPAIR; WOUND HEALING;

ACTIVINS; ANIMALS; CICATRIX; CYTOKINES; FIBROSIS; HUMANS; INFLAMMATION; WOUND HEALING;

EID: 33744515391     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2006.01.001     Document Type: Review

References (120)

1. Phillips D.J. The activin/inhibin family. In: Thomson A., and Lotze M.T. (Eds). The cytokine handbook. fourth ed. vol. 2 (1993), Academic Press 1153-1177
2. Mathews L.S. Activin receptors and cellular signaling by the receptor serine kinase family. Endocr Rev 15 (1994) 310-325
3. Tsuchida K., Nakatani M., Yamakawa N., Hashimoto O., Hasegawa Y., and Sugino H. Activin isoforms signal through type I receptor serine/threonine kinase ALK7. Mol Cell Endocrinol 220 (2004) 59-65
4. Caestecker M. The transforming growth factor-beta superfamily of receptors. Cytokine Growth Factor Rev 15 (2004) 1-11
5. ten Dijke P., and Hill C.S. New insights into TGF-beta-Smad signalling. Trends Biochem Sci 29 (2004) 265-273
6. Nakamura T., Takio K., Eto Y., Shibai H., Titani K., and Sugino H. Activin-binding protein from rat ovary is follistatin. Science 247 (1990) 836-838
7. Schneyer A., Sidis Y., Xia Y., Saito S., del Re E., Lin H.Y., et al. Differential actions of follistatin and follistatin-like 3. Mol Cell Endocrinol 225 (2004) 25-28
8. Harrison C.A., Gray P.C., Vale W.W., and Robertson D.M. Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 16 (2005) 73-78
9. Matzuk M.M., Kumar T.R., Vassalli A., Bickenbach J.R., Roop D.R., Jaenisch R., et al. Functional analysis of activins during mammalian development. Nature 374 (1995) 354-356
10. Risbridger G.R., Schmitt J.F., and Robertson D.M. Activins and inhibins in endocrine and other tumors. Endocrine Rev 22 (2001) 836-858
11. Hübner G., Hu Q., Smola H., and Werner S. Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev Biol 173 (1996) 490-498
12. Cruise B.A., Xu P., and Hall A.K. Wounds increase activin in skin and a vasoactive neuropeptide in sensory ganglia. Dev Biol 271 (2004) 1-10
13. Petri J.B., Schurz S., Gebauer S., and Haustein U.F. Cyclosporine A delays wound healing and apoptosis and suppresses activin beta-A expression in rats. Eur J Dermatol 8 (1998) 104-113
14. Wankell M., Kaesler S., Zhang Y.Q., Florence C., Werner S., and Duan R. The activin binding proteins follistatin and follistatin-related protein are differentially regulated in vitro and during cutaneous wound repair. J Endocrinol 171 (2001) 385-395
15. Munz B., Smola H., Engelhardt F., Bleuel K., Brauchle M., Lein I., et al. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J 18 (1999) 5205-5215
16. Wankell M., Munz B., Hübner G., Hans W., Wolf E., Goppelt A., et al. Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis. EMBO J 20 (2001) 5361-5372
17. Bamberger C., Schärer A., Antsiferova M., Tychsen B., Pankow S., Müller M., et al. Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes. Am J Physiol 167 (2005) 733-747
18. Zhang L., Deng M., Parthasarathy R., Wang L., Mongan M., Molkentin J.D., et al. MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Mol Cell Biol 25 (2005) 60-65
19. Ashcroft G.S., Yang X., Glick A.B., Weinstein M., Letterio J.L., Mizel D.E., et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1 (1999) 260-266
20. Nakamura M., Matzuk M.M., Gerstmayer B., Bosio A., Lauster R., Miyachi Y., et al. Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin. FASEB J 17 (2003) 497-499
21. Becker J.C., Hertel M., Markmann A., Shahin M., Werner S., Domschke W., et al. Dynamics and localization of activin A expression in rat gastric ulcers. Scand J Gastroenterol 38 (2003) 260-267
22. Li Q., Karam S.M., Coerver K.A., Matzuk M.M., and Gordon J.I. Stimulation of activin receptor II signaling pathways inhibits differentiation of multiple gastric epithelial lineages. Mol Endocrinol 12 (1998) 181-192
23. Hübner G., Brauchle M., Gregor M., and Werner S. Activin A: a novel player and inflammatory marker in inflammatory bowel disease?. Lab Invest 77 (1997) 311-318
24. Dignass A.U., Jung S., Harder-d'Heureuse J., and Wiedenmann B. Functional relevance of activin A in the intestinal epithelium. Scand J Gastroenterol 37 (2005) 936-943
25. Dohi T., Ejima C., Kato R., Kawamura Y.I., Kawashima R., Mizutani N., et al. Therapeutic potential of follistatin for colonic inflammation in mice. Gastroenterology 128 (2005) 411-423
26. Yasuda H., Mine T., Shibata H., Eto Y., Hasegawa Y., Takeuchi T., et al. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest 92 (1993) 1491-1496
27. Schwall R.H., Robbins K., Jardieu P., Chang L., Lai C., and Terrell T.G. Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 18 (1993) 347-356
28. Hully J.R., Chang L., Schwall R.H., Widmer H.R., Terrell T.G., and Gillett N.A. Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology 20 (1994) 854-862
29. Russell C.E., Hedger M.P., Brauman J.N., de Kretser D.M., and Phillips D.J. Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2. Mol Cell Endocrinol 148 (1999) 129-136
30. Chen W., Woodruff T.J., and Mayo K.E. Activin A-induced HepG2 liver cell apoptosis: involvement of activin receptors and smad proteins. Endocrinology 141 (2000) 1263-1272
31. Kamamaru C., Yasuda H., and Fujita T. Involvement of Smad proteins in TGF-beta and activin A-induced apoptosis and growth inhibition of liver cells. Hepatol Res 23 (2002) 211-219
32. Takebe K., Wang L., Leal A.M., Macconell L.A., Wiater E., Tomiya T., et al. Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats. Hepatology 38 (2003) 1107-1115
33. Chabicovsky M., Herkner, and Rossmanith W. Overexpression of activin beta(C) or activin beta(E) in the mouse liver inhibits regenerative deoxyribonucleic acid synthesis of hepatic cells. Endocrinology 144 (2003) 3497-3504
34. Gold E.J., Zhang X., Wheatley A.M., Mellor S.L., Cranfield M., Risbridger G.P., et al. BetaA and betaC-activin, follistatin, activin receptor mRNA and betaC activin peptide expression during rat liver regeneration. J Mol Endocrinol 34 (2005) 505-515
35. Takamura K., Tsuchida K., Miyake H., Tashiro S., and Sugino H. Activin and activin receptor expression changes in liver regeneration in rat. J Surg Res 126 (2005) 3-11
36. Date M., Matsuzaki K., Matsushita M., Tahashi Y., Sakitani K., and Inoue K. Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury. J Hepatol 32 (2000) 251-260
37. Oe S., Lemmer E.R., Conner E.A., Factor V.M., Leveen P., Larsson J., et al. Intact signaling by transforming growth factor is not required for termination of liver regeneration in mice. Hepatology 40 (2004) 1098-1105
38. Kogure K., Omata W., Kanzaki M., Zhang Y.Q., Yasuda H., Mine T., et al. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. Gastroenterology 108 (1995) 1136-1142
39. Kogure K., Zhang Y.Q., Kanzaki M., Omata W., Mine T., and Kojima I. Intravenous administration of follistatin: delivery to the liver and effect on liver regeneration after partial hepatectomy. Hepatology 24 (1996) 361-366
40. Kogure K., Zhang Y.Q., Shibata H., and Kojima I. Immediate onset of DNA synthesis in remnant rat liver after 90% hepatectomy by an administration of follistatin. J Hepatol 29 (1998) 977-984
41. Takamura K., Tsuchida K., Miyake H., Tashiro S., and Sugino H. Possible endocrine control by follistatin 315 during liver regeneration based on changes in the activin receptor after a partial hepatectomy in rats. Hepatogastroenterology 52 (2005) 60-99
42. Hughes R.D., and Evans L.W. Activin A and follistatin in acute liver failure. Eur J Gastroenterol Hepatol 15 (2003) 127-131
43. Patella S., Phillips D.J., de Kretser D.M., Evans L.W., Groome N.P., and Sievert W. Characterization of serum activin-A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis. J Hepatol 34 (2001) 576-583
44. Endo D., Kogure K., Hasegawa Y., Maku-uchi M., and Kojima I. Activin A augments vascular endothelial growth factor activity in promoting branching tubulogenesis in hepatic sinusoidal endothelial cells. J Hepatol 40 (2004) 399-404
45. Maeshima K., Maeshima A., Hayasahi Y., Kishi S., and Kojima I. Crucial role of activin A in tubulogenesis of endothelial cells induced by vascular endothelial growth factor. Endocrinology 145 (2004) 3793-3794
46. Lau A.L., Kumar T.R., Nishimori K., Bonadio J., and Matzuk M.M. Activin betaC and betaE genes are not essential for mouse liver growth, differentiation, and regeneration. Mol Cell Biol 20 (2000) 6127-6137
47. De Bleser P.J., Niki T., Xu G., Rogiers V., and Geerts A. Localization and cellular sources of activins in normal and fibrotic rat liver. Hepatology 26 (1997) 905-912
48. Patella S., Phillips D.J., Tchongue J., de Kretser D.M., and Sievert W. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. Am J Physical Gastrointest Liver Physiol 290 (2006) G137-G144
49. Sugiyama M., Ichida T., Sato T., Ishikawa T., Matsuda Y., and Asakura H. Expression of activin A is increased in cirrhotic and fibrotic rat livers. Gastroenterology 114 (1998) 550-558
50. Huang X., Li D.G., Wang Z.R., Wei H.S., Cheng J.L., Zhan Y.T., et al. Expression changes of activin A in the development of hepatic fibrosis. World J Gastroenterol 7 (2001) 37-41
51. 4-induced cirrhosis. Mol Cell Endocrinol 201 (2003) 143-153
52. Wada W., Kuwano H., Hasegawa Y., and Kojima I. The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells. Endocrinology 145 (2004) 2753-2759
53. Ohnishi N., Miyata T., Ohnishi H., Yasuda H., Tamada K., Ueda N., et al. Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis. Gut 52 (2003) 1487-1493
54. Li L., Yi Z., Seno M., and Kojima I. Activin A and betacellulin: effect on regeneration of pancreatic beta-cells in neonatal streptozotocin-treated rats. Diabetes 53 (2004) 608-615
55. Maeshima A., Zhang Y.Q., Nojima Y., Naruse T., and Kojima I. Involvement of the activin-follistatin system in tubular regeneration after renal ischemia in rats. J Am Soc Nephrol 12 (2001) 1685-1695
56. Maeshima A., Nojima Y., and Kojima I. Activin A: an autocrine regulator of cell growth and differentiation in renal proximal tubular cells. Kidney Int 62 (2002) 446-454
57. Yamashita S., Maeshima A., Kojima I., and Nojima Y. Activin A is a potent activator of renal interstitial fibroblasts. J Am Soc Nephrol 15 (2004) 91-101
58. Gaedeke J., Boehleer T., Budde K., Neumayer H.H., and Peters H. Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritis. Nephrol Dial Transplant 20 (2005) 319-328
59. Matsuse T., Fukuchi Y., Eto Y., Matsui H., Hosoi T., Oka T., et al. Expression of immunoreactive and bioactive activin A protein in adult murine lung after bleomycin treatment. Am J Respir Cell Mol Biol 13 (1995) 17-24
60. Aoki F., Kurabayashi M., Hasegawa Y., and Kojima I. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Am J Respir Crit Care Med 172 (2005) 713-720
61. Matsuse T., Ikegami A., Ohga E., Hosoi T., Oka T., Kida K., et al. Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis. Am J Pathol 148 (1996) 707-713
62. Ohga E., Matsuse T., Teramoto S., Katayama H., Nagase T., Fukuchi Y., et al. Effects of activin A on proliferation and differentiation of human lung fibroblasts. Biochem Biophys Res Commun 12 (1996) 391-396
63. Ohga E., Matsuse T., Teramoto S., and Ouchi Y. Activin receptors are expressed on human lung fibroblasts and activin A facilitates fibroblast-mediated collagen gel contraction. Life Sci 66 (2000) 1603-1613
64. Cho S.H., Yao Z., Wang S.W., Alban R.F., Barbers R.G., French S.W., et al. Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. J Immunol 170 (2003) 4045-4052
65. Rosendahl A., Checchin D., Fehniger T.E., ten Dijke P., Heldin C.H., and Sideras P. Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation. Am J Respir Cell Mol Biol 25 (2001) 60-68
66. Funaba M., Ikeda T., Ogawa K., Murakami M., and Abe M. Role of activin A in murine mast cells: modulation of cell growth, differentiation, and migration. J Leukoc Biol 73 (2003) 793-801
67. Inoue S., Orima A., Hosoi T., Matsuse T., Hashimoto M., Yamada R., et al. Expression of follistatin, an activin-binding protein, in vascular smooth muscle cells and arteriosclerotic lesions. Arterioscler Thromb 13 (1993) 1859-1864
68. Inoue S., Orimo A., Hosoi T., Ikegami A., Kozaki K., Ouchi Y., et al. Demonstration of activin-A in arteriosclerotic lesions. Biochem Biophys Res Commun 205 (1994) 441-448
69. Pawlowski J.E., Taylor D.S., Valentine M., Hail M.E., Ferrer P., Kowala M.C., et al. Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo. J Clin Invest 100 (1997) 639-648
70. Kozaki K., Akishita M., Eto M., Yoshizumi M., Toba K., Inoue S., et al. Role of activin-A and follistatin in foam cell formation of THP-1 macrophages. Arterioscler Thromb Vasc Biol 17 (1997) 2389-2394
71. Engelse M.A., Neele J.M., van Achterberg T.A., van Aken B.E., van Schaik R.H., Pannekoek H., et al. Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells. Circ Res 85 (1999) 931-999
72. Engelse M.A., Lardenoye J.H., Neele J.M., Grimbergen J.M., de Vries M.R., Lamfers M.L., et al. Adenoviral activin A expression prevents intimal hyperplasia in human and murine blood vessels by maintaining the contractile smooth muscle cell phenotype. Circ Res 90 (2002) 1128-1134
73. Smith C., Yndestad A., Halvorsen B., Ueland T., Waehre T., Otterdal K., et al. Potential anti-inflammatory role of activin A in acute coronary syndromes. J Am Coll Cardiol 44 (2004) 369-375
74. Yndestad A., Ueland T., Oie E., Florholmen G., Halvorsen B., Attramadal H., et al. Elevated levels of activin A in heart failure: potential role in myocardial remodeling. Circulation 109 (2004) 1379-1385
75. Michel U., Gerber J.E., O'Connor A., Bunkowski S., Bruck W., Nau R., et al. Increased activin levels in cerebrospinal fluid of rabbits with bacterial meningitis are associated with activation of microglia. J Neurochem 86 (2003) 238-245
76. Michel U., Ebert S., Schneider O., Shintani Y., Bunkowski S., Smirnov A., et al. Follistatin (FS) in human cerebrospinal fluid and regulation of FS expression in a mouse model of meningitis. Eur J Endocrinol 143 (2000) 809-816
77. Tretter Y.P., Munz B., Hübner G., ten Bruggencate G., Werner S., and Alzheimer C. Strong induction of activin expression after hippocampal lesion. Neuroreport 7 (1996) 1819-1823
78. Lai M., Gluckman P., Dragunow M., and Hughes P.E. Focal brain injury increases activin βA mRNA in hippocampal neurons. Neuroreport 8 (1997) 2691-2694
79. Munz B., Hübner G., Tretter Y., Alzheimer C., and Werner S. A novel role of activin in inflammation and repair. J Endocrinol 161 (1999) 187-189
80. Sulyok S., Wankell M., Alzheimer C., and Werner S. Activin: an important regulator of wound repair, fibrosis, and neuroprotection. Mol Cell Endocrinol 225 (2004) 127-132
81. Krieglstein K., Suter-Crazzolara C., Fischer W.H., and Unsicker K. TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J 14 (1995) 736-742
82. Iwahore Y., Saito H., Torij K., and Nishivana N. Activin exerts a neurotrophic effect on cultured hippocampal neurons. Brain Res 760 (1997) 52-58
83. Wu D.D., Lai M., Hughes P.E., Sirimanne E., Gluckman P.D., and Williams C.E. Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. Brain Res 835 (1999) 369-378
84. Hughes P.E., Alexi T., Williams C.E., Clark R.G., and Gluckman P.D. Administration of recombinant human activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease. Neuroscience 92 (1999) 197-209
85. Tretter Y.P., Hertel M., Munz B., ten Bruggencate G., Werner S., and Alzheimer C. Induction of activin A is essential for the neuroprotective action of basic fibroblast growth factor in vivo. Nat Med 6 (2000) 812-815
86. Andreasson K., and Worley P.F. Induction of beta-A activin expression by synaptic activity and during neocortical development. Neuroscience 69 (1995) 781-796
87. Foster J.A., Puchowicz M.J., McIntyre D.C., and Herkenham M. Activin mRNA induced during amygdala kindling shows a spatiotemporal progression that tracks the spread of seizures. J Comp Neurol 476 (2004) 91-102
88. Nagamine T., Imamura T., Ishidou Y., Kato M., Murata F., ten Dijke P., et al. Immunohistochemical detection of activin A, follistatin, and activin receptors during fracture healing in the rat. J Orthop Res 16 (1998) 314-321
89. Iemura S., Yamamoto T.S., Takagi C., Uchiyama H., Natsume T., Shimasaki S., et al. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci USA 95 (1998) 9337-9342
90. Uchida S., Doi Y., Kudo H., Furukawa H., Nakamura T., and Fujimoto S. Transient expression of activin betaA mRNA on osteoprogenitor cells in rat bone regeneration after drill-hole injury. Bone 27 (2000) 81-90
91. Ikenoue T., Jingushi S., Urabe K., Okazaki K., and Iwamoto Y. Inhibitory effects of activin-A on osteoblast differentiation during cultures of fetal rat calvarial cells. J Cell Biochem 75 (1999) 206-214
92. Sakai R., Miwa K., and Eto Y. Local administration of activin promotes fracture healing in the rat fibula fracture model. Bone 25 (1999) 191-196
93. Sakai R., Fujita S., Horie T., Ohyama T., Miwa K., Maki T., et al. Activin increases bone mass and mechanical strength of lumbar vertebrae in aged ovariectomized rats. Bone 27 (2000) 91-96
94. Yu E.W., Dolter K.E., Shao L.E., and Yu J. Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies. Clin Exp Immunol 112 (1998) 126-132
95. Ota F., Maeshima A., Yamashita S., Ikeuchi H., Kaneko Y., Kuroiwa T., et al. Activin A induces cell proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum 48 (2003) 2442-2449
96. Hermansson M., Sawaji Y., Bolton M., Alexander S., Wallace A., Begum S., et al. Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin betaA (activin A), a regulatory molecule for chondrocytes. J Biol Chem 279 (2004) 43514-43521
97. Neumann E., Judex M., Kullmann F., Grifka J., Robbins P.D., Pap T., et al. Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway. Gene Therapy 9 (2002) 1508-1519
98. Klein R., Clarke I.J., Hedger M.P., and Robertson D.M. Plasma follistatin concentrations increase following lipopolysaccharide administration in sheep. Clin Exp Pharmacol Physiol 23 (1996) 754-755
99. Phillips D.J., Hedger M.P., McFarlane J.R., Klein R., Clarke I.J., Tilbrook A.J., et al. Follistatin concentrations in male sheep increase following sham castration/castration or injection of interleukin-1 beta. J Endocrinol 151 (1996) 119-124
100. Jones K.L., Brauman J.N., Groome N.P., de Kretser D.M., and Phillips D.J. Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin. Endocrinology 141 (2000) 1905-1908
101. Jones K.L., de Kretser D.M., Clarke I.J., Scheerlinck J.P., and Phillips D.J. Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe. J Endocrinol 182 (2004) 69-80
102. McClure L., O'Connor A.E., Hayward S., Jenkin G., Walker D.W., and Phillips D.J. Effects of age and pregnancy on the circulatory activin response of sheep to acute inflammatory challenge by lipopolysaccharide. J Endocrinol 185 (2005) 139-149
103. Jones K.L., de Kretser D.M., Patella S., and Phillips D.J. Activin A and follistatin in systemic inflammation. Mol Cell Endocrinol 225 (2004) 119-125
104. Michel U., Ebert S., Phillips D., and Nau R. Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia. Eur J Endocrinol 148 (2003) 559-564
105. Petraglia F., Sacerdote P., Cossarizza A., Angioni S., Genazzani A.D., Franceschi C., et al. Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-gamma production. J Clin Endocrinol Metab 72 (1991) 496-502
106. Ogawa K., Funaba M., Mathews L.S., and Mizutani T. Activin A stimulates type IV collagenase (matrix metalloproteinase-2) production in mouse peritoneal macrophages. J Immunol 165 (2000) 2997-3003
107. Eramaa M., Hurme M., Stenman U.H., and Ritvos O. Activin A/erythroid differentiation factor is induced during human monocyte activation. J Exp Med 176 (1992) 1449-1452
108. Shao L., Frigon Jr. N.L., Sehy D.W., Yu A.L., Lofgren J., Schwall R., et al. Regulation of production of activin A in human marrow stromal cells and monocytes. Exp Hematol 20 (1992) 1235-1242
109. Hübner G., and Werner S. Serum growth factors and proinflammatory cytokines are potent inducers of activin expression in cultured fibroblasts and keratinocytes. Exp Cell Res 228 (1996) 106-113
110. Shao L.E., Frigon Jr. N.L., Yu A., Palyash J., and Yu J. Contrasting effects of inflammatory cytokines and glucocorticoids on the production of activin A in human marrow stromal cells and their implications. Cytokine 10 (1998) 227-235
111. Abe M., Shintani Y., Eto Y., Harada K., Fujinaka Y., Kosaka M., et al. Interleukin-1 beta enhances and interferon-gamma suppresses activin A actions by reciprocally regulating activin A and follistatin secretion from bone marrow stromal fibroblasts. Clin Exp Immunol 126 (2001) 64-68
112. Okuma Y., Saito K., O'Connor A.E., Phillips D.J., de Kretser D.M., and Hedger M.P. Reciprocal regulation of activin A and inhibin B by interleukin-1 (IL-1) and follicle-stimulating hormone (FSH) in rat Sertoli cells in vitro. J Endocrinol 185 (2005) 99-110
113. Yu J., Shao L.E., Frigon Jr. N.L., Lofgren J., and Schwall R. Induced expression of the new cytokine, activin A, in human monocytes: inhibition by glucocorticoids and retinoic acid. Immunology 88 (1996) 368-374
114. Yamashita N., Nakajima T., Takahashi H., Kaneoka H., Mizushima Y., and Sakane T. Effects of activin A on IgE synthesis and cytokine production by human peripheral mononuclear cells. Clin Exp Immunol 94 (1993) 214-219
115. Nusing R.M., and Barsig J. Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A. Br J Pharmacol 127 (1999) 919-926
116. Hedger M.P., Phillips D.J., and de Kretser D.M. Divergent cell-specific effects of activin-A on thymocyte proliferation stimulated by phytohemagglutinin, and interleukin 1beta or interleukin 6 in vitro. Cytokine 12 (2000) 595-602
117. Brosh N., Sternberg D., Honigwachs-Shaanani J., Lee B.-C., Shav-Tal Y., Tzehoval E., et al. The plasmacytoma growth inhibitor restrictin-P is an antagonist of interleukin 6 and interleukin 11: identification as a stroma-derived activin A. J Biol Chem 270 (1995) 29594-29600
118. Ohguchi M., Yamato K., Ishihara Y., Koide M., Ueda N., Okahashi N., et al. Activin A regulates the production of mature interleukin-1beta and interleukin-1 receptor antagonist in human monocytic cells. J Interferon Cytokine Res 18 (1998) 491-498
119. Lewandoski M. Conditional control of gene expression in the mouse. Nat Rev Genet 2 (2001) 743-755
120. Engelse M.A., Arkenbout E.K., Pannekoek H., and de Vries C.J.M. Activin and TR3 orphan receptor: two "atheroprotective" genes as evidenced in dedicated mouse models. Clin Exp Pharmacol Physiol 30 (2003) 894-899